OpenVSafe by OpenVAERS
Search V-safe

HBT-31086-19856

3 vaccinations 7 coded responses 37 check-ins 7 free-text entries 3 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
604 / IL
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-30
    Registered in v-safe
  3. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-19
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-19
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cold sweat — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: cold sweat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  16. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  19. 2021-01-26
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-23
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-02
    Survey response — day 42, dose 2
    MedDRA: Dizziness, Nausea — Feeling: Fair · Be unable to work
    Free text: mild nausea without emesis, lightheaded/dizzy - mostly resolved by the end of the day it started
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-04-20
    Survey response — 3 months, dose 2
    MedDRA: Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: axillary lymphadenopathy, fever, tonsillitis, asthma exacerbation (this was more related to change in medication than anything else)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-04-20
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-07-20
    Survey response — 6 months, dose 2
    MedDRA: Lymphadenopathy, Tonsillitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Tonsillitis, lymphadenopathy
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-07-20
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-07-22
  30. 2021-10-11
    Dose 3 — Pfizer-BioNTech
  31. 2021-10-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  32. 2021-10-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  33. 2021-10-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  34. 2021-10-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  35. 2021-10-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  36. 2021-10-18
    Health check-in — day 7, dose 3
    Feeling: Good · Headache, Nausea
    Adult check-in
  37. 2021-10-27
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-01
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-08
    Health check-in — day 28, dose 3
    Feeling: Poor
    Adult check-in
  40. 2021-11-15
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-11-22
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-01-10
    Survey response — 3 months, dose 3
    MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: Good
    Free text: sore throat, congestion
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-04-12
    Survey response — 6 months, dose 3
    MedDRA: Cough, Fatigue, Pre-existing disease, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school
    Free text: congestion, cough, fatigue - allergies
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-10-12
    Survey response — 12 months, dose 3
    MedDRA: Asthma, COVID-19, Hypersensitivity, Infection, Respiratory disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptomatic COVID-19 infection, ongoing respiratory issues following second infection (also related to moving states [inc altitude] and allergy/asthma exacerbation)
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-10-12
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  46. 2022-10-13
  47. 2022-10-13
  48. 2022-10-13
  49. 2022-10-13
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  50. 2022-10-13
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  51. 2022-10-13
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-19Pfizer-BioNTech
32021-10-11Pfizer-BioNTech No

Call center

3 call center cases

3 successful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-20

Systemic reaction (other): cold sweat

Release 4 — day 42, dose 2

2021-03-02

Symptoms: mild nausea without emesis, lightheaded/dizzy - mostly resolved by the end of the day it started

Release 7 — 3 months, dose 2

2021-04-20

Symptoms: axillary lymphadenopathy, fever, tonsillitis, asthma exacerbation (this was more related to change in medication than anything else)

Release 9 — 6 months, dose 2

2021-07-20

Symptoms: Tonsillitis, lymphadenopathy

Release 10 — 3 months, dose 3

2022-01-10

Symptoms: sore throat, congestion

Release 11 — 6 months, dose 3

2022-04-12

Symptoms: congestion, cough, fatigue - allergies

Release 12 — 12 months, dose 3

2022-10-12

Symptoms: Symptomatic COVID-19 infection, ongoing respiratory issues following second infection (also related to moving states [inc altitude] and allergy/asthma exacerbation)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthma · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDizziness ✓ ✓ ✓
SDFatigue · · ✓
SDHypersensitivity · · ✓
SDInfection · · ✓
SDLymphadenopathy · · ✓
SDNausea ✓ ✓ ✓
SDOropharyngeal pain · · ✓
SDPre-existing disease ✓ ✓ ✓
SDRespiratory disorder · · ✓
SDRespiratory tract congestion · · ✓
SDTonsillitis · · ✓
SROCold sweat ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…